Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711

被引：0
|
作者：
Allen, TJ [1 ]
Forbes, JM [1 ]
Yee, LT [1 ]
Thallas, V [1 ]
Thomas, MC [1 ]
Candido, R [1 ]
Jandeleit-Dahm, KA [1 ]
Cooper, ME [1 ]
机构：
[1] Baker Heart Res Inst, Melbourne, Vic, Australia
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3309
引用
收藏
页码：732 / 732
页数：1
相关论文
共 50 条
  • [1] Attenuation of diabetes-associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711
    Calkin, AC
    Yee, LTL
    Thallas, V
    Jandeleit-Dahm, K
    Thomas, MC
    Founds, HW
    Cooper, ME
    Allen, TJ
    Forbes, JM
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 79 - 79
  • [2] Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.
    Forbes, JM
    Thallas, V
    Jerums, G
    Thomas, MC
    Cooper, ME
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 652A - 652A
  • [3] Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-α -: Dependent pathway
    Thallas-Bonke, V
    Lindschau, C
    Rizkalla, B
    Bach, LA
    Boner, G
    Meier, M
    Haller, H
    Cooper, ME
    Forbes, JM
    DIABETES, 2004, 53 (11) : 2921 - 2930
  • [4] A clinical trial of an age cross-link breaker, ALT-711, in systolic hypertension
    Bakris, GL
    Bank, A
    Kass, DA
    Neutel, J
    Preston, R
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 127A - 128A
  • [5] Cardiovascular effects of an advanced glycation end product breaker ALT-711 in adult spontaneously hypertensive rats
    Varagic, J
    Susic, D
    Frohlich, ED
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 290A - 291A
  • [6] Effect of ALT-711, a novel glucose cross-link breaker in the treatment of diastolic heart failure
    Kitzman, DW
    Zile, MR
    Little, WC
    Hundley, W
    O'Brien, TX
    DeGroof, RC
    EUROPEAN HEART JOURNAL, 2003, 24 : 408 - 408
  • [7] Delayed intervention study with age cross-link breaker ALT-711 and ACE-inhibitor quinapril: How to combat diabetes-accelerated atherosclerosis
    Watson, A. M. D.
    Soro-Paavonen, A.
    Thomas, M. C.
    Calkin, A. C.
    Cooper, M. E.
    Jandeleit-Dahm, K. A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 224 - 225
  • [8] Improved flow-mediated arterial vasodilation by advanced glycation cross-link breaker, alagebrium chloride (ALT-711), in older adults with isolated systolic hypertension
    Melenovsky, V
    Clattenburg, L
    Corretti, MC
    Fitzgerald, PJ
    Capriotti, A
    Gerstenblith, G
    Kass, DA
    Zieman, SJ
    CIRCULATION, 2005, 112 (17) : U670 - U670
  • [9] ALT-711, a breaker of advanced glycation endproducts (AGEs), restores large artery elasticity in experimental diabetes
    Wolffenbuttel, BHR
    Boulanger, CM
    Crijns, FRL
    Poitevin, P
    Egan, JJ
    Cerami, A
    Levy, BI
    DIABETES, 1998, 47 : A23 - A23
  • [10] Therapeutic effect of ALT-711, an "AGE cross-link breaker", on renal injury in db/db mice.
    Lee, HB
    Kwon, MK
    Kim, WY
    Kim, J
    Nagai, R
    Horiuchi, S
    Ha, HJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 396A - 396A
12345